116 related articles for article (PubMed ID: 11377601)
1. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England.
Sasieni P; Adams J
Lancet; 2001 May; 357(9267):1490-3. PubMed ID: 11377601
[TBL] [Abstract][Full Text] [Related]
2. Screening and adenocarcinoma of the cervix.
Sasieni P; Castanon A; Cuzick J
Int J Cancer; 2009 Aug; 125(3):525-9. PubMed ID: 19449379
[TBL] [Abstract][Full Text] [Related]
3. Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
Castanon A; Landy R; Sasieni PD
Int J Cancer; 2016 Sep; 139(5):1040-5. PubMed ID: 27096255
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
[TBL] [Abstract][Full Text] [Related]
5. False negative rate in mass screening for cervical cancer.
Sato S; Mikino H; Matsunaga G; Yajima A
Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728
[No Abstract] [Full Text] [Related]
6. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas.
Vizcaino AP; Moreno V; Bosch FX; Muñoz N; Barros-Dios XM; Parkin DM
Int J Cancer; 1998 Feb; 75(4):536-45. PubMed ID: 9466653
[TBL] [Abstract][Full Text] [Related]
7. Changing incidence of invasive adenocarcinoma of the uterine cervix in East Anglia.
Stockton D; Cooper P; Lonsdale RN
J Med Screen; 1997; 4(1):40-3. PubMed ID: 9200062
[TBL] [Abstract][Full Text] [Related]
8. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
Mitchell H; Hocking J; Saville M
Cancer; 2003 Dec; 99(6):336-41. PubMed ID: 14681940
[TBL] [Abstract][Full Text] [Related]
9. Trends in cancer of the cervix uteri in Sweden following cytological screening.
Bergström R; Sparén P; Adami HO
Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
[TBL] [Abstract][Full Text] [Related]
10. Incidence trends of adenocarcinoma of the cervix in 13 European countries.
Bray F; Carstensen B; Møller H; Zappa M; Zakelj MP; Lawrence G; Hakama M; Weiderpass E
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2191-9. PubMed ID: 16172231
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women.
Liu S; Semenciw R; Mao Y
CMAJ; 2001 Apr; 164(8):1151-2. PubMed ID: 11338801
[No Abstract] [Full Text] [Related]
12. [Cervical cancer in the young woman].
Marie G; Barjot P; Crouet H; Mace-Lesech J; Dommesent D; Uzan M
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):743-7. PubMed ID: 8308200
[TBL] [Abstract][Full Text] [Related]
13. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
14. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening.
Bray F; Loos AH; McCarron P; Weiderpass E; Arbyn M; Møller H; Hakama M; Parkin DM
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):677-86. PubMed ID: 15767349
[TBL] [Abstract][Full Text] [Related]
15. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
Nieminen P; Kallio M; Hakama M
Obstet Gynecol; 1995 Jun; 85(6):1017-21. PubMed ID: 7770247
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer prevented by screening: Long-term incidence trends by morphology in Norway.
Lönnberg S; Hansen BT; Haldorsen T; Campbell S; Schee K; Nygård M
Int J Cancer; 2015 Oct; 137(7):1758-64. PubMed ID: 25833121
[TBL] [Abstract][Full Text] [Related]
17. Reducing the burden of glandular carcinomas of the uterine cervix.
Herzog TJ; Monk BJ
Am J Obstet Gynecol; 2007 Dec; 197(6):566-71. PubMed ID: 18060938
[TBL] [Abstract][Full Text] [Related]
18. Intraepithelial carcinoma of the cervix uteri in women aged under 35 years.
Davies SW; Kelly RM
Br Med J; 1971 Nov; 4(5786):525-6. PubMed ID: 5126956
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
Smrkolj S; Rakar S; Mozina A; Erzen M
Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
[TBL] [Abstract][Full Text] [Related]
20. The changing pattern of cervical cancer in Northern Ireland 1965-1989.
Robertson JH; Woodend B
Ulster Med J; 1992 Apr; 61(1):19-23. PubMed ID: 1621297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
